Mineralys Therapeutics, Inc. (MLYS) May 21, 2026 Annual General Meeting Transcript

Good afternoon. This meeting is called to order. I'm John Congleton, Chief Executive Officer of Mineralis, Paracetics, Inc. I'd like to welcome each of you to this annual meeting of shareholders. We appreciate your interest and attendance. Joining me on this call is Adam Levy, our Chief Financial Officer. This meeting is being held pursuant to written notice mailed to all stockholders of record at the close of business on March 25, 2026, which is the record date determined by the Board of Directors. All stockholders, as of the close of business on that date, are entitled to notice of and to vote at this meeting. I have here an affidavit of mailing certifying that the notice of annual meeting was mailed on or about April 8, 2026 to the company's stockholders of record as of the record date. This document will be included with the minutes of the meeting. Lou Larson of L Squared Elections has been appointed the Inspector of Election for this meeting. Mr. Larson has signed an oath of inspector promising to execute faithfully the duties of Inspector of Election. The oath of Inspector of Election will be filed with the minutes of this meeting.

Thank you, Mr. Congleton. 82,451,950 shares of the company's common stock were outstanding and eligible to vote as of March 25th, the record date for this meeting. As the inspector of election, I have determined that proxies representing a majority of Mineralis' outstanding common stock, or approximately 72,685,053 shares, have been received, and accordingly, a quorum is present and the meeting should proceed.

The polls are now open. If you have voted by proxy and will not be changing your vote, then you do not need to vote again as the votes indicated on your proxy will be counted. If you did not vote by proxy or want to change your vote, you may vote today by clicking on the vote here button on your screen and following the instructions provided. For stakeholders voting today, please vote now as we will close the polls shortly after I reviewed the two matters up for both. The first item of business is Proposal 1 in the proxy statement, a collection of three director nominees, Trini Vaz Akaraju, Brian Taylor Slingsby, and Daphne Caritas, who each serve as a Class III director for a three-year term expiring at our 2029 Annual Meeting of Stockholders. The next item of business is Proposal 2 in the proxy statement, ratification of the appointment of Ernst & Young, LLP, as the company's independent registered public accounting firm for the year ending December 31, 2026. I will now pause for a moment while any remaining votes are tallied. Now that stockholders have had the opportunity to vote, I declare the polls closed. The company will disclose the results of the voting in a current report on Form 8K within four business days. All business before this meeting has now been completed. There being no other matters required to come before this annual meeting of stockholders, I declare the formal meeting to be adjourned. Thank you again to all of our stockholders for participating in today's annual meeting.

The meeting has now concluded. You may now disconnect.